Stanislaw Garwicz
Stanislaw Garwicz publishes mostly in Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology, on topics such as Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life and Acute Myeloid Leukemia Research.
- World rank
- #1,202,674 of 7,710,434 ranked researchers
- Rank in Sweden
- #15,444 of 71,437
- Works
- 169
- Citations
- 4.6k
- Citations per work
- 27.3
What does Stanislaw Garwicz research?
Stanislaw Garwicz's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences9355.2%
- Medicine9355.2%
- Everything else6739.7%
- Life Sciences95.1%
- 1Public Health, Environmental and Occupational Health19% of their works
- 2Pediatrics, Perinatology and Child Health14% of their works
- 3Hematology10% of their works
- 4Genetics7% of their works
- 5Oncology6% of their works
- 6Molecular Biology5% of their works
Research topics
- Acute Lymphoblastic Leukemia research
- Childhood Cancer Survivors' Quality of Life
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Retinoids in leukemia and cellular processes
- Genomic variations and chromosomal abnormalities
Which keywords describe Stanislaw Garwicz's research?
The keywords of their largest research topics: Prognostic Factors, Acute Lymphoblastic Leukemia, Childhood Cancer, Childhood Cancer Survivor Study, Pediatric Quality of Life Inventory, Acute Myeloid Leukemia, AML and Rituximab.
- Genomic Rearrangements
- Retinoic Acid
- Lymphoma
- Temozolomide
- Genomic Aberrations
- Rituximab
- AML
- Childhood Cancer Survivor Study
- Acute Lymphoblastic Leukemia
- Prognostic Factors
- Childhood Cancer
- Pediatric Quality of Life Inventory
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Glioblastoma
- Classification
- Acute Promyelocytic Leukemia
- Copy Number Variation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors1113 topics
- Acute Lymphoblastic Leukemia701 topic
- Childhood Cancer701 topic
- Childhood Cancer Survivor Study551 topic
- Pediatric Quality of Life Inventory551 topic
- AML281 topic
- Acute Myeloid Leukemia281 topic
- Rituximab222 topics
- Chronic Lymphocytic Leukemia131 topic
- Genomic Aberrations131 topic
- Glioblastoma111 topic
- Temozolomide111 topic
- Classification91 topic
- Lymphoma91 topic
- Acute Promyelocytic Leukemia81 topic
- Retinoic Acid81 topic
- Copy Number Variation71 topic
- Genomic Rearrangements71 topic
Where does Stanislaw Garwicz work?
Stanislaw Garwicz's main affiliation in the publication record is Lund University, Sweden.
How many publications and citations does Stanislaw Garwicz have?
OpenAlex counts 169 works and 4,612 citations for Stanislaw Garwicz, an h-index of 38, ranking #1,202,674 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Stanislaw Garwicz. Posts are plain text and can be reported.